P3.13C.02 A Plasma Proteomics-Based Model for Clinical Benefit Prediction in Small Cell Lung Cancer Patients Receiving ImmunotherapyDavid R. Gandara, M.A. Schneider, Adam P. Dicker et al.|Journal of Thoracic Oncology|2024Cited by 0